In light of today’s evidence order by Civil Chamber 29 of the Berlin Regional Court regarding the action for eviction taken against the Theater and Komödie am Kurfürstendamm, Norman Schaaf, the Managing Director of CELLS Bauwelt GmbH, had this to say:
“In response to the court’s query regarding the existence of Mars PropCo 1, we cited a series of facts. These prove the company’s capacity to be a party to legal proceedings and therefore the permissibility of this justifiable lawsuit. We are of the firm conviction that our view on the matter will be confirmed on October 18, 2016, thereby finally concluding this spurious discussion which was triggered by the opposing party. After all, the whole thing is obvious anyway: Nobody should be able to use a property over a number of years without paying the associated operating and ancillary costs. The court already clearly indicated this after the first hearing in May.”
About the company:
The CELLS Group, consisting of CELLS Bauwelt GmbH and CELLS Property Investors GmbH, has over 20 years of experience in the development, execution and management of residential and commercial properties both at home and abroad. CELLS Bauwelt GmbH is responsible for the core business areas of project development and execution. Whereas CELLS Property Investors GmbH covers the fields of asset and property management.
An experienced team, made up of over 60 employees at our Munich and Berlin offices, ensures the consistently high quality and sustainability of our real estate portfolio. Our exemplary operational strength and reliability are what make the CELLS Group one of the most widely respected and renowned business partners for tenants, service providers, private investors, family offices and institutional investors. Ever since its founding, the CELLS Group has implemented projects with a total value of over €1.8 billion.
Contact person for queries:
Kay Daniel Zareh
Head of Marketing & Communication
CELLS Group
Kurfürstendamm 207-208
10719 Berlin
Germany
k.zareh@cells-group.com
Tel: +49 (0) 30 / 555 78 03 – 0
Fax: +49 (0) 30 / 555 78 03 – 91
